BioSpace News Archive

Business

Neurodyn Appoints Anthony J. Giovinazzo as Director and Executive Chairman

Neurodyn announce the appointment of Anthony Giovinazzo as a director and Executive Chairman of the Company.

December 19, 2017

·

2 min read

Rucaparib MAA for the Ovarian Cancer Treatment Indication Referred by CHMP to Scientific Advisory Group on Oncology for Review Expected in February 2018

The exact date for the SAG meeting has not yet been set but we expect it to take place in early February 2018.

December 19, 2017

·

6 min read

Genetown

Regenacy Pharmaceuticals to Present a Corporate Update at the 10th Annual Biotech Showcase

Regenacy announced today that Simon S. Jones, Ph.D., President and Chief Executive Officer of Regenacy, is scheduled to present a corporate update at the 10th Annual Biotech Showcase.

December 19, 2017

·

4 min read

Drug Development

Regulus Announces First-in-Human Dosing for Phase I Study of RGLS4326 for the Treatment of Autosomal Dominant Polycystic Kidney Disease

RGLS4326 is being studied in a Phase I randomized, double-blind, placebo-controlled, single ascending dose study designed to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of RGLS4326 administered subcutaneously in healthy volunteers.

December 19, 2017

·

4 min read

Business

MeiraGTx Announces Gene Therapy Manufacturing Collaboration With Oxford Genetics

The collaboration will enable MeiraGTx and Oxford Genetics to develop novel AAV vectors, as well as packaging and producer cell lines to support the manufacturing needs of MeiraGTx’s pipeline of gene therapy product candidates.

December 19, 2017

·

3 min read